Zinc and magnesium are commonly marketed for ADHD, particularly in branded "ADHD mineral" or "calm support" formulations. The evidence on both is real but narrower than the marketing implies. This piece sets out what the trials show, why the geography of the trial population matters more than usual, and what is reasonable to ask a clinician or pharmacist about.
Zinc: the real evidence and the geography problem
Zinc is a cofactor in dopamine and noradrenaline metabolism and has a biologically plausible link to ADHD. Two early randomised trials produced clinically meaningful results:
Bilici 2004, Turkey. Double-blind, placebo-controlled trial in around 400 children with ADHD. Children on zinc sulfate monotherapy showed significant improvement in hyperactivity and impulsivity compared with placebo over twelve weeks [1]. The Bilici study is the largest single ADHD zinc trial in the literature.
Akhondzadeh 2004, Iran. Smaller double-blind trial in around 44 children with ADHD comparing methylphenidate plus zinc with methylphenidate plus placebo. The zinc-adjunct group showed somewhat better outcomes than methylphenidate alone [2].
Arnold 2011, United States. Important counter-evidence. A US pilot trial in around 50 children with ADHD found no significant effect of zinc supplementation, either alone or combined with amphetamine [3].
The reason these results differ is almost certainly background zinc status. Turkey and Iran have populations with significantly higher rates of zinc deficiency than the US and Western Europe. The Turkish and Iranian children were probably starting from a lower zinc status and responding to repletion of a deficiency rather than to pharmacological supplementation in a zinc-replete state. The Sonuga-Barke 2013 broader meta-analysis is consistent with this reading: dietary and supplemental interventions tend to show larger effects in populations with greater baseline nutritional gaps [5].
What this means for UK clinical practice: routine zinc supplementation for ADHD in UK children or adults is not supported by evidence in this population. Where dietary zinc intake is genuinely low (strict vegetarian or vegan diet, very restricted eating, malabsorption), assessing zinc status and addressing deficiency makes sense as part of general nutrition rather than as an ADHD-specific treatment.
Risks of routine zinc supplementation
Worth naming. Long-term high-dose zinc supplementation reduces copper absorption, eventually producing copper deficiency that causes anaemia and neurological symptoms (peripheral neuropathy, weakness, in severe cases gait disturbance). Cases have been documented in adults taking high-dose zinc lozenges for cold prevention and in some adults using zinc-heavy ADHD-marketed supplements. The risk is not theoretical; it is documented in case reports across multiple decades.
Standard nutritional intake levels are well-tolerated; problems emerge with high-dose supplementation continued over months or years without clinical oversight.
Magnesium: a weaker evidence base
Magnesium is involved in NMDA receptor function and GABAergic neurotransmission and has a biologically reasonable link to attention and arousal. The clinical evidence in ADHD specifically is thinner than for zinc:
Mousain-Bosc 2006, France. Open-label study in children with ADHD using combined magnesium and vitamin B6 supplementation. Reported improvement in behavioural symptoms [4]. The trial design (open-label, no blinding) significantly limits how confident the conclusion can be; the broader methodological issues with unblinded dietary trials are covered in the pillar piece.
Subsequent work has been mostly small open-label or quasi-randomised studies with similar design limitations. There is no large, high-quality randomised trial of magnesium for ADHD that meets the bar set by the omega-3 or iron literature. The Sonuga-Barke 2013 meta-analysis did not separate magnesium as a distinct intervention and the overall non-pharmacological dietary effect was small with blinded raters [5].
What this means: claims about magnesium "correcting" ADHD symptoms are running ahead of the published evidence. Magnesium has reasonable effects on sleep onset in some populations (the broader insomnia literature), which may indirectly help ADHD where sleep is part of the picture, but that is not the same as ADHD symptom treatment.
The high-dose vitamin B6 warning
Magnesium ADHD supplements are often combined with vitamin B6 (pyridoxine), and the combined products sometimes contain high B6 doses for what is claimed to be a synergistic effect with magnesium. Worth flagging clearly: long-term high-dose vitamin B6, sustained over months at levels well above standard nutritional intake, causes peripheral sensory neuropathy that can be irreversible. The MHRA and the European Food Safety Authority have both published warnings on this; the EFSA tolerable upper intake level for B6 is set well below typical megadose supplement levels for this reason.
If you or your child are taking a combined magnesium-B6 product marketed for ADHD, check the B6 content carefully. Products at standard nutritional intake levels are fine; products at megadose levels are not safe to take long-term without clinical monitoring.
What about combined "ADHD mineral" formulations
The market for mineral and vitamin blends marketed specifically for ADHD has grown rapidly. The pattern is recognisable from the brain supplements marketing piece: a real but narrow evidence base for a single ingredient is bundled with several other ingredients of uncertain or absent evidence, packaged with an ADHD-specific name, and sold at a substantial markup over generic mineral preparations.
The honest assessment: where the user is genuinely deficient in zinc, iron, vitamin D or another nutrient, addressing that deficiency under clinical guidance is good general medicine. The combined product is not the right tool; standard mineral preparations under clinical supervision are. Where the user is not deficient, the branded ADHD blend is unlikely to help and may carry the copper-deficiency or B6-neuropathy risks above if continued long-term.
How to think about it practically
For a child or adult with ADHD considering zinc, magnesium or combined mineral supplementation:
- Diet first. A varied diet with adequate protein, whole grains, dairy or alternatives, and vegetables provides reasonable zinc and magnesium intake for most UK eaters. Restricted diets (strict vegan, very selective eating, eating disorders) are the cases where deficiency becomes plausible.
- Test where deficiency is clinically suspected. Standard blood tests for zinc and magnesium are available. Random self-supplementation without testing is the wrong approach.
- Disclose to the prescriber. Particularly relevant if your child or you are on stimulant medication, where appetite suppression can reduce dietary intake and where supplements may interact.
- Avoid long-term high-dose products. Particularly zinc above standard nutritional levels for months, or magnesium-B6 products with megadose B6.
- Match expectations to evidence. Even where supplementation works (in genuinely deficient individuals), the effect is small to moderate. It does not replace medication.
What this means in practice
- Zinc has real RCT evidence for ADHD effect in populations with high background zinc deficiency (Turkey, Iran). The same effect did not replicate in a US trial in a likely zinc-replete population.
- Routine zinc supplementation for ADHD in UK or Western European populations is not supported by evidence. Address dietary zinc gaps where they exist; do not megadose without testing.
- Long-term high-dose zinc reduces copper absorption and can produce copper deficiency anaemia and neuropathy. This is documented, not theoretical.
- Magnesium has a weaker evidence base in ADHD specifically; most published studies are open-label or methodologically limited.
- Combined magnesium-B6 products sometimes contain high B6 doses; long-term high-dose B6 causes irreversible peripheral neuropathy. Check the B6 content.
When to speak to a professional
If you are considering zinc, magnesium or combined mineral supplementation for ADHD, speak to your GP, prescribing clinician, pharmacist or a registered dietitian first. Where dietary insufficiency is plausible, blood testing for zinc and magnesium status is appropriate. Do not routinely megadose minerals without clinical oversight. NeuroFX adult ADHD assessment and child ADHD assessment include a review of current supplements alongside prescribed medication; the clinical team can advise on what interacts with the prescribed regimen.
Sources
- Bilici M, Yıldırım F, Kandil S, et al. Double-blind, placebo-controlled study of zinc sulfate in the treatment of attention deficit hyperactivity disorder. Progress in Neuropsychopharmacology and Biological Psychiatry. 2004;28(1):181-190.
- Akhondzadeh S, Mohammadi MR, Khademi M. Zinc sulfate as an adjunct to methylphenidate for the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial. BMC Psychiatry. 2004;4:9.
- Arnold LE, DiSilvestro RA, Bozzolo D, et al. Zinc for attention-deficit/hyperactivity disorder: placebo-controlled double-blind pilot trial alone and combined with amphetamine. Journal of Child and Adolescent Psychopharmacology. 2011;21(1):1-19.
- Mousain-Bosc M, Roche M, Polge A, Pradal-Prat D, Rapin J, Bali JP. Improvement of neurobehavioral disorders in children supplemented with magnesium-vitamin B6. I. Attention deficit hyperactivity disorders. Magnesium Research. 2006;19(1):46-52.
- Sonuga-Barke EJ, Brandeis D, Cortese S, et al. Nonpharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments. American Journal of Psychiatry. 2013;170(3):275-289.
- NICE. Attention deficit hyperactivity disorder: diagnosis and management. NG87. National Institute for Health and Care Excellence. https://www.nice.org.uk/guidance/ng87



